Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other financing activities (2023 - 2024)

Historic Other financing activities for Contineum Therapeutics (CTNM) over the last 2 years, with Q1 2024 value amounting to $140000.0.

  • Contineum Therapeutics' Other financing activities rose 270000.0% to $140000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $157000.0, marking a year-over-year change of. This contributed to the annual value of $22000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q1 2024, Contineum Therapeutics' Other financing activities is $140000.0, which was up 270000.0% from $1000.0 recorded in Q4 2023.
  • Over the past 5 years, Contineum Therapeutics' Other financing activities peaked at $140000.0 during Q1 2024, and registered a low of $1000.0 during Q4 2023.